Sort
261,768 grants matching “gene therapy”
A 3D vascularized islet biomimetic to model type 1 diabetes
$1,087,069Maike Sander · University Of California, San Diego · UG3 · FY2019 · DK
Persistent modulation of microbiota to enhance HIV vaccination
$1,086,868Nichole Rose Klatt · University Of Washington · R01 · FY2017 · AI
Gene Therapy for Metabolic Disorders
$1,086,784Chester B Whitley · University Of Minnesota · P01 · FY2008 · HD
Mammalian iron-sulfur cluster biogenesis
$1,086,753Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
Investigation of viral and host determinants of gammaherpesvirus pathogenesis
$1,086,648Laurie T Krug · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Novel interventions for gammaherpesvirus infection and AIDS-Related Malignancies
$1,086,648Laurie T Krug · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Genes And Gene Products As Immunoadjuvants
$1,086,518Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Transgenic Animal Models Of Human Immune Defects
$1,086,518Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Ultrasensitive Single-Genome Sequencing to Study HIV Transmission and Evolution
$1,086,504Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Effects of Antiretroviral Therapy on Transcriptional Activity of HIV Proviruses
$1,086,504Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
New Radiopharmaceuticals and New Paradigms in Positron Emission Tomography
$1,086,464Dale O Kiesewetter · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2009 · EB
Comprehensive Sickle Cell Center
$1,086,293Clinton H. Joiner · Cincinnati Childrens Hosp Med Ctr · U54 · FY2011 · HL
Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)
$1,086,202Michael D Geschwind · University Of California, San Francisco · R01 · FY2023 · AG
Vascular remodeling in patients with rare genetic disorders
$1,086,198Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
A RESOURCE FOR MAGNETIC RESONANCE AND OPTICAL RESEARCH
$1,086,140University Of Pennsylvania · P41 · FY2002 · RR
Bacterial Mechanisms and Host Pharmacokinetic Factors that Determine Persistence
$1,086,119David Alland · Boston Medical Center · U19 · FY2014 · AI
MPSA Pathology Coordinating Center
$1,086,084University Of Colorado Denver · U01 · FY2002 · DK
MPSA Pathology Coordinating Center
$1,086,084University Of Colorado Denver · U01 · FY2003 · DK
Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease
$1,086,082Robert W. Mahley · Gabaeron, Inc. · R44 · FY2021 · AG
Adult-to-Adult Living Donor Liver Transplantation Study Data Coordinating Center
$1,086,000Robert M Merion · University Of Michigan At Ann Arbor · U01 · FY2009 · DK
Novel Sources of Transplantable Beta-cell Replacements
$1,085,951Markus Grompe · Oregon Health & Science University · U01 · FY2010 · DK
Novel Sources of Transplantable Beta-cell Replacements
$1,085,949Markus Grompe · Oregon Health & Science University · U01 · FY2011 · DK
1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study
$1,085,815Fernando J Martinez · Univ Of Massachusetts Med Sch Worcester · UH3 · FY2025 · HL
Determinants of inception of inflammation in inflammatory bowel diseases
$1,085,723Ashwin N Ananthakrishnan · Massachusetts General Hospital · R01 · FY2022 · DK
GENE THERAPY STRATEGIES FOR SICKLE CELL DISEASE
$1,085,566University Of California San Francisco · P01 · FY2003 · HL